SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001437749-22-006009
Filing Date
2022-03-11
Accepted
2022-03-11 16:15:24
Documents
2
Group Members
DRUGCRAFTERS, LPDUGABOY INVESTMENT TRUSTHIGHLAND SMALL-CAP EQUITY FUNDNEXPOINT REAL ESTATE OPPORTUNITIES, LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G jdond20220309_sc13g.htm SC 13G 134059
2 EXHIBIT 99.1 ex_345533.htm EX-99.1 13255
  Complete submission text file 0001437749-22-006009.txt   148937
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Subject) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-81821 | Film No.: 22733303
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 CRESCENT COURT SUITE 700 DALLAS TX 75201
Business Address
DONDERO JAMES D (Filed by) CIK: 0001228922 (see all company filings)

Type: SC 13G